(Q44988545)

8 December 2017

title

A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex (English)

1 reference

8 December 2017

0 references

1 reference

2

1 reference

8 December 2017

Gries JM

1

1 reference

8 December 2017

Verotta D

series ordinal

3

1 reference

8 December 2017

Jacobson M

series ordinal

4

1 reference

8 December 2017

Sheiner LB

series ordinal

5

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Clinical Pharmacology & Therapeutics

8 December 2017

published in

1 reference

8 December 2017

volume

61

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

70-82

1 reference

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Antihypertensive medication-taking. Investigation of a simple regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

The use of drugs in combination for the treatment of cancer: rationale and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Semiparametric models for longitudinal data with application to CD4 cell numbers in HIV seroconverters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

A new look at the statistical model identification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Meta-analysis and evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

Self-modelling with random shift and scale parameters and a free-knot spline shape function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990183-1

10.1016/S0009-9236(97)90183-1

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference